Biotech safety debate
Open your materials, follow the steps, then turn in your work.
Argue how much regulation high-school and amateur biotechnology should face given its risks and benefits.
1. Open your materials
2. Start the work
Read the briefing on community and classroom biotech labs.
Show all 5 required steps
- Read the briefing on community and classroom biotech labs.
- Choose a position on the right level of oversight.
- List two reasons balancing innovation against biosafety.
- Debate in your group, tracking claims about containment and selection markers.
- Reflect on what rules you would set for your own lab.
Lost your place? If you lost your place, you should be on the step 'choose a position on the right level of oversight.' Reread the briefing, pick your side, then list your two reasons before the group debate.
Check your work before submitting
- You can defend a position on biotech regulation.
- You weighed innovation against biosafety risk.
3. Turn in your work
DueCheck Schoology- Hand in
- One sentence explaining why antibiotic-resistance selection markers are a specific biosafety concern, plus three lab rules you would require.
How to submit and name your file
Use the submission route shown on today's today's page.
In Schoology, open your course and the assignment for this lesson. Attach your file, select Submit, and check that it appears in the submission.
PDF upload helpYou get two school days for every day you were absent, so this deadline moves with you.
How this lesson connects
Keep using what you learned last class: Each recombinant DNA step uses a sequence-specific enzyme or reagent so that the insert and vector join correctly, and controls are built in so that you can verify the outcome instead of assuming it. Today: Biotechnology needs institutional oversight because even small-scale work spreads real biosafety risk (like antibiotic-resistance genes) when containment fails, so the rule must follow the organism rather than the size of the lab.
Optional: listen or watch a unit review▸
Need help? Warm-up, timing, and directions▸
💡 Big idea: Biotechnology needs institutional oversight because even small-scale work spreads real biosafety risk (like -resistance genes) when containment fails, so the rule must follow the organism rather than the size of the lab.
- 0-5 minWarm-up: what could go wrong if a transformed bacterium escaped the lab?
- 5-20 minRead briefing; choose a regulation position and list two containment-grounded reasons
- 20-40 minSmall-group debate tracking BSL, selection marker, and disposal claims
- 40-55 minFull-class debrief: what rule would every classroom biotech lab need?
- 55-70 minReflection: write three rules you would require in your own lab
- 70-80 minExit ticket: one sentence on why selection markers are a specific biosafety concern
- • You're about to run a real experiment in this class, so today we ask: how safe is that?
- • Amateur and classroom biotech is growing, and the rules are still being debated.
- • Your argument today should use specific containment terms: BSL levels, selection markers, disposal.
- • What you decide today frames the mindset you carry into Wednesday's wet lab.
- • Biosafety levels (BSL-1 through BSL-4) classify the containment required for different organisms.
- • -resistance selection markers pose a real environmental risk if organisms escape containment.
- • Classroom biotech operates at BSL-1 and requires proper disposal of transformed organisms.
PLTW connection and today's work
Open Problem 6 Molecular Biology in Action in your myPLTW course shell and navigate to the transformation activity to review the biotech safety debate prompt.
Today's stopping point: You are opening the transformation unit; the debate confirms your safety mindset before Wednesday's wet lab.
PLTW activity titles identify the course connection. If your account will not open, use the posted materials for today and tell Mr. Mendoza. Do not mark an online activity complete unless you completed it.
Course connection
- Project 6.1.2 Construction and Cloning of Recombinant DNA
Use the turn-in directions at the top of this page. Do not create a second submission unless your teacher asks for one.
Show another explanation or a smaller first step
Need help? Choose a starting point
Lesson resources: reading, slides, and vocabulary▸
The deck carries the prior idea forward, lets you inspect an analogy, maps the rule to biology, and ends with the same evidence decision and exit ticket used on this page.
Generated from this lesson's canonical data with a red-team citation check.
Each recombinant DNA step uses a sequence-specific or reagent so that the insert and vector join correctly, and controls are built in so that you can verify the outcome instead of assuming it.
Biotechnology needs institutional oversight because even small-scale work spreads real biosafety risk (like -resistance genes) when containment fails, so the rule must follow the organism rather than the size of the lab.
A review board sorts scientific evidence, stakeholder needs, possible benefits, possible burdens, and uncertainty before choosing a policy.
- Which statements are scientific evidence?
- Which statements express a value or priority?
- Who receives the benefit and who carries the burden?
Use science to estimate consequences, then state the value judgment and tradeoff that determine the decision.
A review-board model organizes reasoning but does not make one ethical principle automatically outweigh every other principle.
- • Evidence cards map to source-backed findings.
- • Stakeholder cards map to affected people and priorities.
- • The recommendation maps to an explicit tradeoff with a named uncertainty.
Driving question: A high school lab and a community 'DIY bio' space both want to grow -resistant bacteria. How much oversight should each one face, and why should it be the same rule for both?
What you already know: Each recombinant DNA step uses a sequence-specific or reagent so that the insert and vector join correctly, and controls are built in so that you can verify the outcome instead of assuming it.
New idea: Biotechnology needs institutional oversight because even small-scale work spreads real biosafety risk (like -resistance genes) when containment fails, so the rule must follow the organism rather than the size of the lab.
Visual or model: F1. F1. A lesson illustration or teaching diagram for Biotech safety debate. Use it with E1-E3; it is a model or context image, not experimental or patient data. What to notice: Trace the labeled system, test, or design relationship and identify which evidence should trigger revision.
- Observe or measure the relevant feature in biotech debate.
- Organize the observation with a stable evidence ID.
- Apply this rule: Use science to estimate consequences, then state the value judgment and tradeoff that determine the decision.
- Choose the option the evidence supports and state the limit of the conclusion.
Real biomedical example: A high school lab and a community 'DIY bio' space both want to grow -resistant bacteria. How much oversight should each one face, and why should it be the same rule for both?
What the evidence supports: E1-E3 and F1 support the daily take-home when the response meets the stated success criteria.
What it cannot prove: The package does not support claims beyond this lesson's or any real patient diagnosis.
- • : The process by which a bacterial cell takes up foreign DNA, such as a , from its surroundings and begins using those new genes.
- • selection: The process of choosing among options using set criteria, such as picking the best design solution or the strongest candidate.
- • : A visible cluster of identical microorganisms growing on a plate, all descended from a single original cell.
- • digest: To cut DNA at specific sequences using restriction enzymes, producing defined fragments that scientists can sort, study, or join together.
- • : A lab method that uses an electric field to pull DNA fragments through a gel so they separate by size and show up as bands.
- • : A set of DNA fragments of known sizes run alongside samples in to measure the length of unknown bands.
Use it now: Choose one decision option. Cite E1 and E3, then explain how the rule connects the evidence to your choice.
Go further, optional: The source links below are optional enrichment. Every fact required for today's local evidence decision appears in this lesson package.
A defensible biomedical decision separates scientific evidence from value judgments, identifies who may benefit or be burdened, and states the uncertainty and tradeoffs that remain.
Limit: Scientific evidence can inform the options and likely consequences, but it cannot choose a single value-neutral answer.
Use science to estimate consequences, then state the value judgment and tradeoff that determine the decision.
Limit: A review-board model organizes reasoning but does not make one ethical principle automatically outweigh every other principle.
You can defend a position on biotech regulation.
Limit: E3 defines the classroom product or success criterion. It is not independent scientific evidence and cannot justify a clinical or causal claim.
PLTW-BFH-2027-05-05 · Simulated classroom evidence scenario
Your role: biomedical design team member
Decision: Your team must decide what the evidence from biotech debate supports before submitting the exit response named on today's page.
- • Set the same rule for both spaces, because the resistance gene carries the same risk in either place.
- • Require strict oversight of the DIY bio space only, since a school project is too small to need real rules.
- • Nobody has said who would inspect either space or enforce disposal, so ask that before setting oversight levels.
Response: State one choice, cite at least two evidence IDs, explain the rule that connects them, and add one limitation. Submit it as the exit response.
Claim ceiling: Today's evidence supports a classroom claim about biotech debate. It cannot prove causation, diagnose a real patient, or justify action outside this room.
Reason for review: Your team must decide what the evidence from biotech debate supports before submitting the exit response named on today's page.
Context: Biotechnology is regulated by containment level, not by who owns the lab, because the same organism carries the same risk whether it is engineered by a company or by a student.
- • T1: Read the briefing on community and classroom biotech labs.
- • T2: Choose a position on the right level of oversight.
- • T3: List two reasons balancing innovation against biosafety.
- • T4: Debate in your group, tracking claims about containment and selection markers.
- • T5: Reflect on what rules you would set for your own lab.
- • E1: A defensible biomedical decision separates scientific evidence from value judgments, identifies who may benefit or be burdened, and states the uncertainty and tradeoffs that remain.
- • E2: Use science to estimate consequences, then state the value judgment and tradeoff that determine the decision.
- • E3: You can defend a position on biotech regulation.
Measurements: Use only the measurements, units, graph, or counts supplied in today's task. No additional patient measurement is implied.
Figure finding: Teaching diagram for Biotech debate. Trace the labeled system, test, or design relationship and identify which evidence should trigger revision. This is a teaching model, not patient or experimental data.
Uncertainty: This is a composite classroom scenario. Missing history, measurements, or confirmation tests remain unknown and limit the conclusion.
Mean = sum of values / number of values. Median = middle ordered value. Range = maximum - minimum.
For 2, 4, 4, and 10: mean = 20 / 4 = 5, median = 4, and range = 10 - 2 = 8.
Mean, median, and range keep the measurement unit. Order the values before finding the median.
Calculate the requested summary for today's supplied values, then write what it reveals and what it hides.
- • The solution must address the stated need in biotech debate.
- • The decision must be supported by E1-E3.
- • The final product must make the success criteria visible.
- • Complete the work inside the 80-minute block.
- • Use only supplied or teacher-approved materials and evidence.
- • Do not trade , accessibility, or privacy for speed.
- • and evidence quality: must pass before scoring other criteria.
- • User need and effectiveness: highest scored criterion.
- • Time, cost, and ease of use: compare only after and effectiveness pass.
Test evidence: For each option, record the E1-E3 result that supports or fails each criterion. Do not assign a score without a named observation.
- Version or option tested
- Criterion met or missed
- Evidence ID and result
- Revision made
- Reason for the revision
- Need and user
- Criteria and constraints
- Chosen option and evidence
- Test result
- Revision and reason
Students often think Students assume classroom biotech is unregulated 'because it is just a school project' and that real rules only apply to big companies.. The trap: The rules follow the organism, not the address. A classroom runs at 1 (BSL-1) and must still or bleach every transformed plate before disposal, because an -resistance gene loose in the environment is the same gene whether it escaped a company or a school sink.
Parallel scenario (not today's question): A biology class and a public library both want to offer students the same cheap mail-in DNA ancestry kit, which reads a person's genetic markers and stores the raw data on a company server. Should both settings follow the same consent and data rules, and why?\n\nClaim: Both the classroom and the library should follow the same baseline rules, requiring informed consent and a plan for deleting the raw genetic data, because the risk to a person comes from the genetic information itself, not from which building the kit is used in.\n\nEvidence: A consumer DNA kit reads inherited markers that can reveal ancestry, carrier status for some diseases, and family relationships a person did not know about. That data is copied to a company server, where it can be sold, breached, or shared with third parties. Genetic data is also permanent and shared with relatives, so one person's test can expose information about siblings and parents who never agreed to be tested. The cost of a kit has dropped low enough that a school or a library can buy them in bulk, which means many young people could be tested quickly with no medical professional involved.\n\nReasoning: The reason both settings need the same baseline is that the hazard travels with the DNA sample and the stored data, not with the location. If the classroom followed strict consent rules but the library did not, a student could simply get tested next door and face the same privacy exposure, so a weaker rule in one place undermines the stronger rule in the other. Requiring informed consent makes sure the person, and a guardian for a minor, understands what will be revealed before the sample is sent. Requiring a deletion plan limits how long the permanent data sits on a server where it could leak. Matching the rules across both settings treats the actual source of risk, the genetic information, instead of assuming a school is automatically safer than a library. That is why the same baseline should apply to both.
This model shows the level of evidence and organization needed to complete: Worked CER on a parallel case: a model argument about how much oversight a low-cost consumer DNA ancestry kit should face when used in a school genetics unit, showing the Claim/Evidence/Reasoning format and depth students should match on today's own prompt without answering it.
- Name the prompt or task.
- Answer it directly with the key evidence.
- Check that the response matches the requested format.
Keep the structure. Replace the question, facts, measurements, and evidence. Then recheck units, vocabulary, and whether the conclusion goes beyond the evidence.
Also due today: Submit your exit ticket on Schoology before leaving class.
- CER:
- Claim, Evidence, Reasoning: make a claim, back it with evidence, explain your reasoning.
- SOP:
- Standard Operating Procedure, the exact steps to follow (especially in a lab).
- Tracker:
- Your PLTW progress log where you record completed evidence.
- myPLTW:
- The PLTW course site where you do the online activities. Find it in Clever with your Microsoft sign-in, right next to Schoology.
Tap the speaker to hear a term. Add two of these to your notebook glossary with a definition and an example in your own words.
Pick just 2 or 3 words from today and make them yours: write what each one means in your own words, name the context clue or evidence that helped, then give one example from what you actually did in Biotech safety debate. Try your own words first; the glossary is there if you get stuck. This is voluntary and counts as extra credit, so keep it short.
Saved on this device. Show Mr. Mendoza or add these to your notebook glossary to claim the extra credit.
Classroom documents for this lesson are posted in Schoology. Open Clever, then Schoology, and find each one by the name shown on its card.
Use this if you were absent, got stuck, or need another pass before you submit the lesson artifact.
Placement rationale
Matched , , molecular evidence by path:Biomedical-Innovations/Problem-6_Molecular-Biology/6.1_Molecular-Biology; keywords:transformation, , molecular. Score 146. Visibility: student-schoology (student-facing resource; link through Schoology rather than local path).
Use this if you were absent, got stuck, or need another pass before you submit the lesson artifact.
Placement rationale
Matched , , molecular evidence by path:Biomedical-Innovations/Problem-6_Molecular-Biology/6.1_Molecular-Biology; keywords:gel, molecular. Score 142. Visibility: student-schoology (student-facing resource; link through Schoology rather than local path).
Use this if you were absent, got stuck, or need another pass before you submit the lesson artifact.
Placement rationale
Matched , , molecular evidence by path:Biomedical-Innovations/Problem-6_Molecular-Biology/6.1_Molecular-Biology; keywords:transformation, molecular. Score 142. Visibility: student-schoology (student-facing resource; link through Schoology rather than local path).
Sign in to Clever with your district Microsoft account to open Schoology or myPLTW. Follow today's posted steps. If myPLTW will not open, use the posted alternative and tell Mr. Mendoza. Turn in your completed work through the Schoology assignment.
Practice: try a question, then check your answer▸
Claim ceiling for this check: Today's evidence supports a classroom claim about biotech debate. It cannot prove causation, diagnose a real patient, or justify action outside this room.
A classmate says, 'Our transformed plates are safe to throw in the regular trash because the bacteria are just E. coli.' Are they right? Explain.
Write an answer and pick a confidence to unlock the key.
Fast retrieval with instant answers, not the commit-then-reveal check above. Try each from memory first: write what you remember about the earlier units, then check yourself here.
Missed class or ready for more?▸
Run this before you touch the bench. It is built from the real lab procedure, so the decisions you make here are the ones you will make with the equipment in your hands.
What today's skills lead to. These are real health-science careers this course builds toward. Tap one to see, on the US Department of Labor's O*NET site, what the job actually involves, what it pays, and how fast it is growing.
Post a 150-word stance on regulating amateur biotech, then reply to a classmate who argued for a different level of oversight.
Use the submission route shown on today's today's page.
Class still runs. Complete the online activity above (it's self-guided). Need the concept taught without a teacher? Use this authoritative explainer:
Learn.Genetics (University of Utah): gel electrophoresisYou've passed Unit 2, so the optional extra-credit track is open. Complete reserved-unit work from home, including virtual labs, for extra credit. Each item shows its correct submission route.
Open the extra-credit track- CompleteEvery required part of the artifact is present, nothing left blank.
- AccurateThe science and the data are correct and match the evidence.
- Scientific reasoningYou explain your claim with evidence and reasoning (CER), not just an answer.
- Professional communicationClear, organized, labeled, and written the way a clinician or scientist would.
- SubmittedGo to Schoology to turn this in. Submit one PDF. Put your first and last name in the document header. Name the file: FirstName LastName - Assignment Title - YYYY-MM-DD.pdf. If you cannot get in, see Mr. Mendoza. Do not skip the work.
This week
My Progress dashboard